Tag: Liver Disease
-
Hepatitis A Outbreak in Czech Republic Could Last 1-2 Years
The Czech hepatitis A outbreak: a developing public health challenge The hepatitis A outbreak in the Czech Republic, which began last April in isolated pockets of Ostrava, has grown into a nationwide concern. With 2,141 confirmed cases and 26 deaths—ten of them in Prague—the situation exceeds last year’s toll, when 676 people fell ill and…
-
Czech Hepatitis A Outbreak: experts warn it could last 1-2 more years and push for targeted vaccination
Overview of the Czech Hepatitis A Situation Public health officials in the Czech Republic are monitoring a significant Hepatitis A outbreak that began in April 2025 in Ostrava and has since spread to multiple regions. As of now, there are about 2,141 reported cases and 26 deaths, including ten in Prague. This marks the largest…
-
Ganoderma lucidum Shields Liver Damage from High-Fat Diets
Overview: High-Fat Diets, Liver Lipotoxicity, and the Search for Protection Long-term consumption of a high-fat diet (HFD) is linked to progressive liver damage, metabolic dysfunction, and fears of nonalcoholic fatty liver disease. In a recent study, researchers investigated how HFD drives lipid accumulation, inflammatory responses, and cellular stress in the liver, and whether Ganoderma lucidum…
-
Fatty Liver Cure: Could Pemafibrate and Telmisartan Reversethe Disease?
New Study Suggests a Surprising Duo for Fatty Liver Cure Fatty liver disease, or MASLD/NAFLD as it’s increasingly called, has earned its reputation as a global silent killer. The condition unfolds quietly as excess fat accumulates in liver cells, potentially progressing to inflammation, fibrosis, and even cirrhosis or liver cancer. While lifestyle changes remain the…
-
Fatty Liver Cure: How Two Common Cardiovascular Drugs Could Reverses Fatty Liver Disease
The Breakthrough: A New Hope for Fatty Liver Disease Fatty liver disease, or MASLD (formerly NAFLD), affects millions worldwide and has long lacked a proven medical cure. A recent study from researchers at the University of Barcelona suggests a provocative approach: combining two widely used cardiovascular drugs—pemafibrate and telmisartan—to actively reduce liver fat and improve…
-
NUH and Siemens Collaborate on Ultrasound Tech for Liver Diagnostics
NUH and Siemens Team Up to Advance Liver Disease Diagnostics Singapore’s National University Hospital (NUH) and Siemens Healthineers have announced a collaborative study to explore cutting-edge ultrasound technologies aimed at improving liver disease diagnostics. The project signals a growing push in the medical imaging field to combine reliable non-invasive tests with intelligent data analysis, offering…
-
NUH and Siemens Team Up to Advance Ultrasound Diagnostics for Liver Disease
NUH and Siemens Collaborate to Advance Liver Disease Diagnostics The National University Hospital (NUH) has announced a collaborative research effort with Siemens Healthineers to study and develop ultrasound-based diagnostics for liver disease. The partnership brings together NUH’s clinical expertise and Siemens’ imaging technology to explore new ways to detect, characterize, and monitor liver conditions, including…
-
NUH and Siemens Expand Ultrasound Tech to Revolutionize Liver Disease Diagnostics
NUH and Siemens Partner to Advance Ultrasound-Based Liver Diagnostics Hospitals in Singapore’s healthcare landscape are witnessing a significant collaboration as National University Hospital (NUH) teams up with Siemens Healthineers to study and develop next-generation ultrasound technologies focused on liver disease diagnostics. This partnership underscores a broader push toward non-invasive, accurate, and accessible liver imaging that…
-
NT Leads Australia in Hepatitis B Care as Diagnoses Rise and Mortality Falls
NT Becomes national leader in hepatitis B care as diagnoses rise, mortality falls In the Northern Territory, a striking story is unfolding. Rather than signaling a crisis, a surge in hepatitis B diagnoses is being read by health workers as a sign of stronger, more accessible care. The territory has become a benchmark in Australia…
-
CORE Model: Simple Blood Tests Predict Liver Disease Risk
What is the CORE model? A new tool, the CORE model, is being developed to help primary care teams assess the risk of serious liver diseases. The aim is to identify patients who are at higher risk of conditions such as cirrhosis, liver cancer, or the potential need for a liver transplant within the next…